Inventor · disambiguated record
Adam Cook
Also filed as: COOK ADAM · COOK ADAM W · COOK ADAM WADE
39 granted patents·11 pending applications·220 citations·filing 2002–2024
97Inventor score
Top patents by PatentIndex Score
50 records- 0198US10112942B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Oct 30, 2018·29 cites·30 claims
- 0297US10953005B1Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Granted Mar 23, 2021·4 cites·16 claims
- 0397US10689377B2KRas G12C inhibitorsMIRATI THERAPEUTICS INC·Filed 2018·Granted Jun 23, 2020·16 cites·57 claims
- 0497US10137124B2Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Nov 27, 2018·12 cites·29 claims
- 0596US10208024B22-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinasesARRAY BIOPHARMA INC·Filed 2016·Granted Feb 19, 2019·32 cites·27 claims
- 0696US10172851B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Jan 8, 2019·8 cites·29 claims
- 0794US11414404B2Compounds for the treatment of BRAF-associated diseases and disordersARRAY BIOPHARMA INC·Filed 2020·Granted Aug 16, 2022·5 cites·14 claims
- 0894US10555944B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Feb 11, 2020·10 cites·12 claims
- 0991US10172845B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Jan 8, 2019·4 cites·29 claims
- 1089US11634417B2Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Granted Apr 25, 2023·2 cites·52 claims
- 1189US10144734B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Dec 4, 2018·6 cites·30 claims
- 1289US7067506B2Compounds useful for inhibiting Chk1ICOS CORP·Filed 2002·Granted Jun 27, 2006·31 cites·25 claims
- 1388US11780835B2Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinasesARRAY BIOPHARMA INC·Filed 2021·Granted Oct 10, 2023·1 cites·9 claims
- 1488US10441581B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Oct 15, 2019·2 cites·29 claims
- 1588US7608618B2Urea or thiourea substituted 1,4-pyrazine compounds useful as anti-cancer agents and for inhibiting Chk1ICOS CORP·Filed 2005·Granted Oct 27, 2009·9 cites·2 claims
- 1687US11998545B2Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2023·Granted Jun 4, 2024·0 cites·14 claims
- 1785US9763942B2Serine/threonine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Sep 19, 2017·5 cites·18 claims
- 1884US11104676B2Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinasesARRAY BIOPHARMA INC·Filed 2019·Granted Aug 31, 2021·1 cites·4 claims
- 1984US10745419B2Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrileLOXO ONCOLOGY INC·Filed 2018·Granted Aug 18, 2020·2 cites·19 claims
- 2084US7560462B2Compounds useful for inhibiting CHK1ICOS CORP·Filed 2005·Granted Jul 14, 2009·7 cites·3 claims
- 2182US10881652B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2019·Granted Jan 5, 2021·2 cites·14 claims
- 2282US10154995B2Serine/threonine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Dec 18, 2018·3 cites·18 claims
- 2382US2024101553A1Kras g12c inhibitorsMIRATI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2481US11098064B2Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbontrileLOXO ONCOLOGY INC·Filed 2020·Granted Aug 24, 2021·1 cites·9 claims
- 2581US9670208B2Serine/threonine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Jun 6, 2017·4 cites·19 claims
- 2680US2023090520A1Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitorsARRAY BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2779US8093244B2Heteroaryl urea derivatives useful for inhibiting CHK1DIAZ FRANK·Filed 2006·Granted Jan 10, 2012·9 cites·3 claims
- 2879US2024124453A1Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 2978US8716498B26-substituted phenoxychroman carboxylic acid derivativesARRAY BIOPHARMA INC·Filed 2013·Granted May 6, 2014·2 cites·1 claims
- 3078US2024174666A1PYRAZOLO[3,4-b]PYRIDINE COMPOUNDS AS INHIBITORS OF TAM AND MET KINASESARRAY BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 3178US2023373999A1Kras g12c inhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3276US9096567B26-substituted phenoxychroman carboxylic acid derivativesARRAY BIOPHARMA INC·Filed 2014·Granted Aug 4, 2015·2 cites·31 claims
- 3376US8569522B26-substituted phenoxychroman carboxylic acid derivativesBURGESS LAURENCE E·Filed 2009·Granted Oct 29, 2013·3 cites·37 claims
- 3476US2021186959A1Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitorsARRAY BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 3576US2025066357A1Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 3675US11247990B1Bicyclic fused pyridine compounds as inhibitors of TAM kinasesARRAY BIOPHARMA INC·Filed 2018·Granted Feb 15, 2022·1 cites·20 claims
- 3774US11884664B2Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2022·Granted Jan 30, 2024·0 cites·16 claims
- 3874US8785445B27-phenoxychroman carboxylic acid derivativesCOOK ADAM·Filed 2009·Granted Jul 22, 2014·4 cites·14 claims
- 3972US11648243B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Granted May 16, 2023·0 cites·20 claims
- 4072US9556139B26-substituted phenoxychroman carboxylic acid derivativesARRAY BIOPHARMA INC·Filed 2015·Granted Jan 31, 2017·1 cites·14 claims
- 4171US11634409B2Compounds for the treatment of BRAF-associated diseases and disordersARRAY BIOPHARMA INC·Filed 2022·Granted Apr 25, 2023·0 cites·42 claims
- 4271US8183289B24-substituted phenoxyphenylacetic acid derivativesDOHERTY GEORGE·Filed 2007·Granted May 22, 2012·2 cites·13 claims
- 4369US11807651B2Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrileLOXO ONCOLOGY INC·Filed 2021·Granted Nov 7, 2023·0 cites·11 claims
- 4465US10766881B22-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinasesARRAY BIOPHARMA INC·Filed 2019·Granted Sep 8, 2020·0 cites·21 claims
- 4564US2010105683A1Compounds useful for inhibiting chk1KEEGAN KATHLEEN S·Filed 2009·Application pending·0 cites
- 4663US12187721B2Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2019·Granted Jan 7, 2025·0 cites·22 claims
- 4749US8492437B24-substituted phenoxyphenylacetic acid derivativesDOHERTY GEORGE A·Filed 2012·Granted Jul 23, 2013·0 cites·2 claims
- 4849US2020216416A1Quinoline compounds as inhibitors of tam and met kinasesARRAY BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 4939US2012065195A1Compounds for treating neurodegenerative diseasesCLARK CHRISTOPHER T·Filed 2011·Application pending·0 cites
- 5035US2012157448A1Compounds for treating neurodegenerative diseasesCOOK ADAM·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →